Pfizer Inc
PFE - NEW YORK STOCK EXCHANGE, INC.
Industry: Pharmaceuticals
Market Cap: 136.6 B
IPO Date: Jan 17, 1944
Country: US
Currency: USD
Shares Outstanding: 5.7 B
6 month performance
Recent News
Pfizer Inc. (PFE) Pushes Forward in Cancer and Hemophilia Treatments
9/21/2025
In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Pfizer Inc. is one of them. Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to expand its mRNA vaccine and specialty medicine portfolio while maintaining focus on oncology, immunology, and infectious diseases. The company, widely recognized […]
Source: Yahoo
How the FDA Is Taking Aim at the Surreal World of TV Drug Ads
9/21/2025
The agency’s crackdown represents a significant rise in scrutiny of pharmaceutical ads in recent years.
Source: Yahoo
3 Bargain Stocks for Investors on a Budget
9/21/2025
If every one of your dollars counts, make sure you're getting the biggest possible bang for your buck.
Source: Yahoo
Dividend Paying Stocks With Strong Yields: Pfizer’s (PFE) Appeal Explained
9/21/2025
Pfizer Inc. (NYSE:PFE) is included among the 12 Best Dividend Paying Stocks to Buy Now. Pfizer Inc. (NYSE:PFE) ranks among the world’s top pharmaceutical companies, with vast resources to back its research and development efforts. Still, the process of discovering, testing, and getting approval for new drugs is complex, time-intensive, and carries no guarantees, no […]
Source: Yahoo
Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon
9/20/2025
There is a "for sale" sign on the sector, and these two stocks look particularly attractive at their current levels.
Source: Yahoo
A Look at Pfizer’s (PFE) Valuation Following Fresh Legal Rulings and Positive COVID Vaccine Trial Data
9/20/2025
If you have been watching Pfizer (PFE) lately, you probably noticed a fresh round of headlines. These include legal developments around its COVID-19 vaccine patents and an antitrust settlement related to generic drug pricing. In addition, upbeat Phase 3 trial data for their next-generation COVID-19 vaccine has focused investor attention on the stock. These events are prompting conversations about the company’s ongoing risks and revenue resilience as it navigates the post-pandemic market...
Source: Yahoo
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill
9/20/2025
A high yield is only one part of the story when it comes to picking dividend stocks.
Source: Yahoo
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
9/20/2025
These stocks are bargains now. But they probably won't be by the end of this decade.
Source: Yahoo
CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids
9/19/2025
Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.
Source: Yahoo
US Weighs Trump-Branded Website to Help Shop for Cheaper Drugs
9/19/2025
The initiative is part of Trump’s demands that drugmakers reduce their prices to align them with what other developed countries pay, according to the people, who spoke on condition of anonymity to discuss plans that are not yet public. The proposed website would allow patients to search for specific medicines and be connected with platforms that sell them, the people said.
Source: Yahoo
PFE vs. AZN: Which Cancer-Focused Drug Giant Is the Better Pick?
9/19/2025
AstraZeneca and Pfizer both boast strong oncology pipelines, but growth paths, dividends and challenges set them apart for investors.
Source: Yahoo
Arvinas reboots, cuts more staff; Porges joins Lazard
9/19/2025
Pfizer and Arvinas plan to out-license their partnered drug vepdegestrant. Elsewhere, Novo shared more data for oral Wegovy and Vertex reached a deal in Italy for coverage of its gene editing medicine Casgevy.
Source: Yahoo
ISG Announces 2025 ISG Women in Digital Award Winners for EMEA
9/19/2025
LONDON, September 19, 2025--Leaders with Shell, Pfizer, BBC, Genpact, Santander and WNS have been named winners of the 2025 ISG Women in Digital Awards for EMEA.
Source: Yahoo
3 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
9/19/2025
Everything is going great for the stock market right now. But a plot twist could be on the way.
Source: Yahoo
AstraZeneca: Consistent Growth And Upcoming Catalysts Make This A Buy
9/19/2025
AstraZeneca is a leading global pharmaceutical company with strong growth in oncology, diversified revenues, and a robust pipeline. Click to read why AZN is a Buy.
Source: SeekingAlpha
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut
9/18/2025
The reworked ACIP is making its debut. On Friday, the panelists weigh the suite of new Covid vaccines from Pfizer, Moderna and Novavax.
Source: Yahoo
Formation Bio Expands Leadership Team With Top Biotech and Pharma Executives to Accelerate AI-Driven Drug Development
9/18/2025
Formation Bio, the AI-native pharmaceutical company revolutionizing drug development, today announced the appointment of four world-class leaders to its senior team: Louis Brenner, MD, as Chief Medical Officer; Daniel Neil, PhD, as Chief Technology Officer; and seasoned industry veterans Frank D'Amelio and Dashyant Dhanak, PhD, as Senior Advisors and members of our Investment Advisory Committee, alongside Mikael Dolsten MD, PhD. All of these leaders join the core group of executives at Formation
Source: Yahoo
Pfizer: Dividend Cushion Ratio Brings Yield Sustainability Into Question
9/18/2025
Pfizer Inc. faces significant uncertainty due to declining COVID-19 sales and potential policy changes. Learn more about PFE stock here.
Source: SeekingAlpha